Implication of degradation systems, the Valosin-Containing Protein and new drugs on APP metabolism : fundamental and applied aspects to Alzheimer's disease
Identifieur interne : 000070 ( France/Analysis ); précédent : 000069; suivant : 000071Implication of degradation systems, the Valosin-Containing Protein and new drugs on APP metabolism : fundamental and applied aspects to Alzheimer's disease
Auteurs : Caroline Evrard [France]Source :
Descripteurs français
English descriptors
- mix :
Abstract
Alzheimer's disease (AD) is a slow, progressive and irreversible neurodegenerative disease. There are two histopathological hallmarks found in AD brains: neurofibrillary tangles, caused by the intraneuronal accumulation of Tau protein aggregates in a hyper- and abnormally phosphorylated form; and amyloid deposits in the brain parenchyma which are mainly composed of amyloid peptides (Aβ) aggregates derived from the cleavage of the amyloid precursor protein (APP). AD physiopathology also includes a deregulation of protein homeostasis and degradation systems: proteasome, autophagy and the endosome/lysosome pathway, which are the main processes involved in the elimination of protein aggregates. Many evidences suggest that overproduction and aggregation of Aβ peptides are the main causes of AD and that strategies aiming to reduce their production and/or improve their clearance represent attractive approaches for AD therapeutics. Thus, this thesis aimed to study the respective contribution of g-secretase, proteasome and lysosomes in APP degradation; to determine the biological mode of action of chloroquine derivatives on APP metabolism in relationship with the Valosin-Containing Protein (VCP), supposed to be the target of these molecules, and at the same time, to study the relationship between APP and VCP. First, we have demonstrated that APP and its carboxy-terminal fragments (APP-CTFs) were mainly degraded by two pathways: g-secretase and the endosome/lysosome pathway. Next, we showed that VCP was involved in APP trafficking and processing. Finally, we have discovered that the action of our molecules does not depend on VCP but that they are indirect modulators of the β-secretase activity, reducing Aβ peptides secretion. In conclusion, this work contributed to a better understanding of APP metabolism and its degradation processes but also to characterize the biological effects of new indirect β-secretase inhibitors.
Url:
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Hal, to step Corpus: 000128
- to stream Hal, to step Curation: 000128
- to stream Hal, to step Checkpoint: 000023
- to stream Main, to step Merge: 000B83
- to stream Main, to step Curation: 000B83
- to stream Main, to step Exploration: 000B83
- to stream France, to step Extraction: 000070
Links to Exploration step
Hal:tel-02373421Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Implication of degradation systems, the Valosin-Containing Protein and new drugs on APP metabolism : fundamental and applied aspects to Alzheimer's disease</title>
<title xml:lang="fr">Implication des systèmes de dégradation cellulaire, de la protéine VCP et de nouvelles molécules sur le métabolisme de l’APP : aspects fondamentaux et appliqués à la maladie d’Alzheimer</title>
<author><name sortKey="Evrard, Caroline" sort="Evrard, Caroline" uniqKey="Evrard C" first="Caroline" last="Evrard">Caroline Evrard</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-545691" status="VALID"> <orgName>Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer</orgName>
<orgName type="acronym">JPArc - U1172 Inserm</orgName>
<date type="start">2015-01-01</date>
<desc> <address> <addrLine>Faculté de Médecine Henri Warembourg - Pôle Recherche - 1 place de verdun 59045 Lille cedex.</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://crjpa.fr/</ref>
</desc>
<listRelation> <relation active="#struct-164505" type="direct"></relation>
<relation name="U1172" active="#struct-303623" type="direct"></relation>
<relation active="#struct-425779" type="direct"></relation>
<relation active="#struct-451073" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-164505" type="direct"><org type="institution" xml:id="struct-164505" status="VALID"> <orgName>Université Lille Nord de France (COMUE)</orgName>
<desc> <address> <addrLine>365 bis, rue Jules Guesde BP 50458 - 59658 Villeneuve d’Ascq Cedex </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.cue-lillenorddefrance.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U1172" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-425779" type="direct"><org type="institution" xml:id="struct-425779" status="VALID"> <orgName>Centre Hospitalier Régional Universitaire [Lille]</orgName>
<orgName type="acronym">CHRU Lille</orgName>
<desc> <address> <addrLine>2, avenue Oscar Lambret - 59037 Lille Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.chru-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-451073" type="direct"><org type="institution" xml:id="struct-451073" status="VALID"> <orgName>Université Lille 2 - Faculté de Médecine </orgName>
<desc> <address> <addrLine>1, place de Verdun 59045 Lille Cédex</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:tel-02373421</idno>
<idno type="halId">tel-02373421</idno>
<idno type="halUri">https://tel.archives-ouvertes.fr/tel-02373421</idno>
<idno type="url">https://tel.archives-ouvertes.fr/tel-02373421</idno>
<date when="2018-11-20">2018-11-20</date>
<idno type="wicri:Area/Hal/Corpus">000128</idno>
<idno type="wicri:Area/Hal/Curation">000128</idno>
<idno type="wicri:Area/Hal/Checkpoint">000023</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000023</idno>
<idno type="wicri:Area/Main/Merge">000B83</idno>
<idno type="wicri:Area/Main/Curation">000B83</idno>
<idno type="wicri:Area/Main/Exploration">000B83</idno>
<idno type="wicri:Area/France/Extraction">000070</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Implication of degradation systems, the Valosin-Containing Protein and new drugs on APP metabolism : fundamental and applied aspects to Alzheimer's disease</title>
<title xml:lang="fr">Implication des systèmes de dégradation cellulaire, de la protéine VCP et de nouvelles molécules sur le métabolisme de l’APP : aspects fondamentaux et appliqués à la maladie d’Alzheimer</title>
<author><name sortKey="Evrard, Caroline" sort="Evrard, Caroline" uniqKey="Evrard C" first="Caroline" last="Evrard">Caroline Evrard</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-545691" status="VALID"> <orgName>Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer</orgName>
<orgName type="acronym">JPArc - U1172 Inserm</orgName>
<date type="start">2015-01-01</date>
<desc> <address> <addrLine>Faculté de Médecine Henri Warembourg - Pôle Recherche - 1 place de verdun 59045 Lille cedex.</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://crjpa.fr/</ref>
</desc>
<listRelation> <relation active="#struct-164505" type="direct"></relation>
<relation name="U1172" active="#struct-303623" type="direct"></relation>
<relation active="#struct-425779" type="direct"></relation>
<relation active="#struct-451073" type="direct"></relation>
</listRelation>
<tutelles><tutelle active="#struct-164505" type="direct"><org type="institution" xml:id="struct-164505" status="VALID"> <orgName>Université Lille Nord de France (COMUE)</orgName>
<desc> <address> <addrLine>365 bis, rue Jules Guesde BP 50458 - 59658 Villeneuve d’Ascq Cedex </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.cue-lillenorddefrance.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U1172" active="#struct-303623" type="direct"><org type="institution" xml:id="struct-303623" status="VALID"> <idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc> <address> <addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-425779" type="direct"><org type="institution" xml:id="struct-425779" status="VALID"> <orgName>Centre Hospitalier Régional Universitaire [Lille]</orgName>
<orgName type="acronym">CHRU Lille</orgName>
<desc> <address> <addrLine>2, avenue Oscar Lambret - 59037 Lille Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.chru-lille.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-451073" type="direct"><org type="institution" xml:id="struct-451073" status="VALID"> <orgName>Université Lille 2 - Faculté de Médecine </orgName>
<desc> <address> <addrLine>1, place de Verdun 59045 Lille Cédex</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</analytic>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="mix" xml:lang="en"><term>APP</term>
<term>Alzheimer’s disease</term>
<term>Degradation systems</term>
<term>VCP</term>
<term>Vasolin containing protein</term>
<term>Β-secretase modulators</term>
</keywords>
<keywords scheme="mix" xml:lang="fr"><term>APP</term>
<term>Inhibiteurs indirects de la β- sécrétase</term>
<term>Maladie d’Alzheimer</term>
<term>VCP</term>
<term>Voie de dégradation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"> <p>Alzheimer's disease (AD) is a slow, progressive and irreversible neurodegenerative disease. There are two histopathological hallmarks found in AD brains: neurofibrillary tangles, caused by the intraneuronal accumulation of Tau protein aggregates in a hyper- and abnormally phosphorylated form; and amyloid deposits in the brain parenchyma which are mainly composed of amyloid peptides (Aβ) aggregates derived from the cleavage of the amyloid precursor protein (APP). AD physiopathology also includes a deregulation of protein homeostasis and degradation systems: proteasome, autophagy and the endosome/lysosome pathway, which are the main processes involved in the elimination of protein aggregates. Many evidences suggest that overproduction and aggregation of Aβ peptides are the main causes of AD and that strategies aiming to reduce their production and/or improve their clearance represent attractive approaches for AD therapeutics. Thus, this thesis aimed to study the respective contribution of g-secretase, proteasome and lysosomes in APP degradation; to determine the biological mode of action of chloroquine derivatives on APP metabolism in relationship with the Valosin-Containing Protein (VCP), supposed to be the target of these molecules, and at the same time, to study the relationship between APP and VCP. First, we have demonstrated that APP and its carboxy-terminal fragments (APP-CTFs) were mainly degraded by two pathways: g-secretase and the endosome/lysosome pathway. Next, we showed that VCP was involved in APP trafficking and processing. Finally, we have discovered that the action of our molecules does not depend on VCP but that they are indirect modulators of the β-secretase activity, reducing Aβ peptides secretion. In conclusion, this work contributed to a better understanding of APP metabolism and its degradation processes but also to characterize the biological effects of new indirect β-secretase inhibitors.</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><country name="France"><noRegion><name sortKey="Evrard, Caroline" sort="Evrard, Caroline" uniqKey="Evrard C" first="Caroline" last="Evrard">Caroline Evrard</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000070 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000070 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= France |étape= Analysis |type= RBID |clé= Hal:tel-02373421 |texte= Implication of degradation systems, the Valosin-Containing Protein and new drugs on APP metabolism : fundamental and applied aspects to Alzheimer's disease }}
This area was generated with Dilib version V0.6.33. |